Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
4.230
-0.070 (-1.63%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Treace Medical Concepts Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Treace Medical Concepts stock has a consensus rating of "Hold" and an average price target of $4.67. The average 1-year stock price forecast is 10.40% higher than the current stock price, while the lowest is $3.00 (-29.08%) and the highest is $7.00 (+65.48%).
Price Target: $4.67 (+10.40%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Treace Medical Concepts stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Financial | Truist Financial | Hold Maintains $2 → $4 | Hold | Maintains | $2 → $4 | -5.44% | Jul 16, 2026 |
| Lake Street | Lake Street | Buy Reiterates $7 | Buy | Reiterates | $7 | +65.48% | May 11, 2026 |
| UBS | UBS | Hold Maintains $2.5 → $2.25 | Hold | Maintains | $2.5 → $2.25 | -46.81% | Mar 2, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $3 | Hold | Maintains | $3 | -29.08% | Mar 2, 2026 |
Financial Forecast
Revenue This Year
206.27M
from 212.69M
Decreased by -3.02%
Revenue Next Year
221.80M
from 206.27M
Increased by 7.53%
EPS This Year
-0.91
from -0.80
EPS Next Year
-0.90
from -0.91
EPS and Forward PE are based on non-GAAP adjusted numbers.